Rock Springs Capital Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-727,673
| Closed | -$4.51M | – | 111 |
|
|
2024
Q2 | $4.51M | Hold |
727,673
| – | – | 0.14% | 84 |
|
|
2024
Q1 | $6.87M | Hold |
727,673
| – | – | 0.17% | 86 |
|
|
2023
Q4 | $4.91M | Hold |
727,673
| – | – | 0.12% | 81 |
|
|
2023
Q3 | $3.23M | Hold |
727,673
| – | – | 0.09% | 90 |
|
|
2023
Q2 | $2.4M | Hold |
727,673
| – | – | 0.06% | 104 |
|
|
2023
Q1 | $2.07M | Buy |
727,673
+343,083
| +89% | +$978K | 0.05% | 103 |
|
|
2022
Q4 | $2.8M | Hold |
384,590
| – | – | 0.07% | 100 |
|
|
2022
Q3 | $3.11M | Hold |
384,590
| – | – | 0.08% | 104 |
|
|
2022
Q2 | $1.88M | Sell |
384,590
-50,000
| -12% | -$245K | 0.05% | 115 |
|
|
2022
Q1 | $10.3M | Sell |
434,590
-22,400
| -5% | -$530K | 0.26% | 80 |
|
|
2021
Q4 | $8.08M | Buy |
456,990
+1,700
| +0.4% | +$30.1K | 0.19% | 100 |
|
|
2021
Q3 | $12.8M | Buy |
+455,290
| New | +$12.8M | 0.27% | 94 |
|